LINC00211

Across TCGA pan-cancer cohorts, LINC00211 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of LINC00211’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where LINC00211 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC00211 is over-expressed in tumor, although a few such as LUAD and LUSC show the opposite, repressed pattern.

LUAD, LUSC, and UCEC are the cancer types where LINC00211 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00211 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Male	III,IV	−0.353	<.001	9	view →
LUSC	Male	III,IV	−0.467	<.001	8	view →
UCEC	All	All	−0.244	<.001	6	view →
BRCA	All	II,III,IV	−0.142	<.001	6	view →
KICH	All	All	−0.219	<.001	5	view →
PAAD	Female	All	−0.175	.004	2	view →
BLCA	All	All	−0.082	.014	2	view →
COAD	Male	All	−0.069	.008	2	view →
KIRC	Male	II,III,IV	−0.064	.026	2	view →
PRAD	All	All	−0.062	.003	2	view →
READ	Female	All	−0.090	.026	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

LINC00211–LUAD

Open the LUAD breakdown →